Recombinant activated factor VII for haemophilia patients with inhibitors undergoing orthopaedic surgery: A review of the literature

Haemophilia

Volumn 14, Issue 2, 2008, Pages 233-241

  Obergfell, Achim ^a   Auvinen, Marja Kaisa ^b   Mathew, Prasad ^c  

^a Novo Nordisk FemCare AG   (Switzerland)

^b Finnish Red Cross   (Finland)

^c UNIVERSITY OF NEW MEXICO SCHOOL OF MEDICINE   (United States)

Author keywords

Haemophilia; Inhibitor; Orthopaedic; rFVIIa; Surgery

Indexed keywords

AUTOANTIBODY; BLOOD CLOTTING FACTOR 8 ANTIBODY; BLOOD CLOTTING FACTOR 9 ANTIBODY; RECOMBINANT BLOOD CLOTTING FACTOR 7A; RECOMBINANT BLOOD CLOTTING FACTOR 8; UNCLASSIFIED DRUG;

ABSENCE OF SIDE EFFECTS; ANEMIA; ARTHROPATHY; BLEEDING; BOLUS INJECTION; CELLULITIS; CLINICAL EFFECTIVENESS; CLINICAL TRIAL; CONTINUOUS INFUSION; DRUG DOSE COMPARISON; DRUG DOSE INCREASE; DRUG DOSE REDUCTION; DRUG MECHANISM; DRUG MEGADOSE; DRUG SAFETY; DRUG TOLERANCE; HEMARTHROSIS; HEMATOMA; HEMOPHILIA; HEMOPHILIA A; HEMOPHILIA B; HUMAN; IMMUNOADSORPTION; INFECTION; LOW DRUG DOSE; ORTHOPEDIC SURGERY; POSTOPERATIVE COMPLICATION; POSTOPERATIVE HEMORRHAGE; PREVALENCE; PRIORITY JOURNAL; PSEUDOTUMOR; RECOMMENDED DRUG DOSE; REVIEW; SINGLE DRUG DOSE; SYNOVECTOMY; SYNOVIORTHESIS; THROMBOCYTOPENIA; THROMBOEMBOLISM; THROMBOPHLEBITIS; TOTAL KNEE REPLACEMENT; UNSPECIFIED SIDE EFFECT;

BLOOD COAGULATION FACTOR INHIBITORS; FACTOR VIIA; HEMOPHILIA A; HEMOSTASIS, SURGICAL; HEMOSTATICS; HUMANS; MUSCULOSKELETAL DISEASES; ORTHOPEDIC PROCEDURES; POSTOPERATIVE HEMORRHAGE; RECOMBINANT PROTEINS;

EID: 40349100414     PISSN: 13518216     EISSN: 13652516     Source Type: Journal    
DOI: 10.1111/j.1365-2516.2007.01617.x     Document Type: Review

References (48)